307 related articles for article (PubMed ID: 32144419)
1. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
[TBL] [Abstract][Full Text] [Related]
3. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
[TBL] [Abstract][Full Text] [Related]
4. Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease.
Gignac T; Trépanier G; Paquet V; Ferland S; Carreau AM
Can J Diabetes; 2023 Oct; 47(7):603-610. PubMed ID: 37352972
[TBL] [Abstract][Full Text] [Related]
5. Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.
Yoo JH; Kang M; Kim G; Hur KY; Kim JH; Sinn DH; Jin SM
J Diabetes Investig; 2021 Jul; 12(7):1252-1262. PubMed ID: 33135331
[TBL] [Abstract][Full Text] [Related]
6. The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population.
Zhang X; Zhou X; Han X; Fu Z; Wang L; Li Y; Ji L
Metab Syndr Relat Disord; 2020 Aug; 18(6):284-290. PubMed ID: 32460629
[No Abstract] [Full Text] [Related]
7. Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum.
Xin Z; Huang J; Cao Q; Wang J; He R; Hou T; Ding Y; Lu J; Xu M; Wang T; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
J Diabetes; 2022 Sep; 14(9):606-619. PubMed ID: 36163589
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
[TBL] [Abstract][Full Text] [Related]
9. Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study.
Kong L; Ye C; Wang Y; Dou C; Zheng J; Wang S; Lin H; Zhao Z; Li M; Xu Y; Chen Y; Lu J; Xu M; Wang W; Ning G; Bi Y; Wang T
J Diabetes; 2024 Jan; 16(1):e13459. PubMed ID: 37584361
[TBL] [Abstract][Full Text] [Related]
10. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
[TBL] [Abstract][Full Text] [Related]
11. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V
J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
[TBL] [Abstract][Full Text] [Related]
13. Impact of mismatches in HbA
Gonzalez A; Deng Y; Lane AN; Benkeser D; Cui X; Staimez LR; Ford CN; Khan FN; Markley Webster SC; Leong A; Wilson PWF; Phillips LS; Rhee MK
Diabet Med; 2020 Apr; 37(4):689-696. PubMed ID: 31721287
[TBL] [Abstract][Full Text] [Related]
14. Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose.
Maagensen H; Junker AE; Jørgensen NR; Gluud LL; Knop FK; Vilsbøll T
J Clin Endocrinol Metab; 2018 May; 103(5):2042-2049. PubMed ID: 29506157
[TBL] [Abstract][Full Text] [Related]
15. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
[TBL] [Abstract][Full Text] [Related]
16. One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.
Fiorentino TV; Andreozzi F; Mannino GC; Pedace E; Perticone M; Sciacqua A; Perticone F; Sesti G
J Clin Endocrinol Metab; 2016 Nov; 101(11):4030-4038. PubMed ID: 27459528
[TBL] [Abstract][Full Text] [Related]
17. Review of methods for detecting glycemic disorders.
Bergman M; Abdul-Ghani M; DeFronzo RA; Manco M; Sesti G; Fiorentino TV; Ceriello A; Rhee M; Phillips LS; Chung S; Cravalho C; Jagannathan R; Monnier L; Colette C; Owens D; Bianchi C; Del Prato S; Monteiro MP; Neves JS; Medina JL; Macedo MP; Ribeiro RT; Filipe Raposo J; Dorcely B; Ibrahim N; Buysschaert M
Diabetes Res Clin Pract; 2020 Jul; 165():108233. PubMed ID: 32497744
[TBL] [Abstract][Full Text] [Related]
18. The prevalence, risk factors, and screening measure for prediabetes and diabetes among Emirati overweight/obese children and adolescents.
Al Amiri E; Abdullatif M; Abdulle A; Al Bitar N; Afandi EZ; Parish M; Darwiche G
BMC Public Health; 2015 Dec; 15():1298. PubMed ID: 26704130
[TBL] [Abstract][Full Text] [Related]
19. Patterns of changes in fasting plasma glucose, hemoglobin A1c and the area under the curve during oral glucose tolerance tests in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.
Safari S; Amini M; Aminorroaya A; Feizi A
Acta Diabetol; 2021 Mar; 58(3):371-381. PubMed ID: 33084981
[TBL] [Abstract][Full Text] [Related]
20. Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
Wewer Albrechtsen NJ; Junker AE; Christensen M; Hædersdal S; Wibrand F; Lund AM; Galsgaard KD; Holst JJ; Knop FK; Vilsbøll T
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G91-G96. PubMed ID: 28971838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
